New evidence for a role of melatonin in glucose regulation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Best practice & research. Clinical endocrinology & metabolism

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.beem.2010.09.001PMID 21112029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigational melatonin receptor agonists

  2010cited by this paper
• Long‐term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2‐diabetic Goto‐Kakizaki rats

  2010cited by this paper
• Exocytotic Properties of Human Pancreatic β‐cells

  2009cited by this paper
• Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene

  2009cited by this paper
• Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion

  2009cited by this paper
• Modulation of the cGMP signaling pathway by melatonin in pancreatic β‐cells

  2009cited by this paper
• Oscillatory control of insulin secretion.

  2009cited by this paper
• Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes

  2009cited by this paper
• A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals

  2009cited by this paper
• A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk

  2009cited by this paper
• Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose.

  2009cited by this paper
• Variants in MTNR1B influence fasting glucose levels

  2009cited by this paper
• G-allele of Intronic rs10830963 in MTNR1B Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release

  2009cited by this paper
• A Generic Approach for the Purification of Signaling Complexes That Specifically Interact with the Carboxyl-terminal Domain of G Protein-coupled Receptors*S

  2008cited by this paper
• The PDZ Protein Mupp1 Promotes Gi Coupling and Signaling of the Mt1 Melatonin Receptor*

  2008cited by this paper
• Insulin modulates norepinephrine-mediated melatonin synthesis in cultured rat pineal gland.

  2008cited by this paper
• Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine β-Cell Function

  2008cited by this paper
• Rhythmic expression of clock genes in the ependymal cell layer of the third ventricle of rodents is independent of melatonin signaling

  2008cited by this paper
• Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

  2008cited by this paper
• Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes

  2008cited by this paper
• Function and expression of melatonin receptors on human pancreatic islets

  2008cited by this paper
• Involvement of the cGMP pathway in mediating the insulin‐inhibitory effect of melatonin in pancreatic β‐cells

  2008cited by this paper
• Ghrelin Uses Gαi2 and Activates Voltage-Dependent K+ Channels to Attenuate Glucose-Induced Ca2+ Signaling and Insulin Release in Islet β-Cells

  2007cited by this paper
• Activation of insulin and IGF‐1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets

  2007cited by this paper
• Purification and Identification of G Protein-coupled Receptor Protein Complexes under Native Conditions*S

  2007cited by this paper
• Melatonin and type 2 diabetes – a possible link? *

  2007cited by this paper
• Melatonin, endocrine pancreas and diabetes

  2007cited by this paper
• Evidence for the expression of both the MT1‐ and in addition, the MT2‐melatonin receptor, in the rat pancreas, islet and β‐cell

  2007cited by this paper
• Parallel signaling pathways of melatonin in the pancreatic β‐cell

  2006cited by this paper
• Melatonin in the multi‐oscillatory mammalian circadian world

  2006cited by this paper
• Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin‐receptor status

  2006cited by this paper
• Melatonin and Human Rhythms

  2006cited by this paper
• Are G Protein‐Coupled Receptor Heterodimers of Physiological Relevance?—Focus on Melatonin Receptors

  2006cited by this paper
• Melatonin Plays a Crucial Role in the Regulation of Rhythmic Clock Gene Expression in the Mouse Pars Tuberalis

  2005cited by this paper
• Melatonin stimulates inositol‐1,4,5‐trisphosphate and Ca2+ release from INS1 insulinoma cells

  2005cited by this paper
• Rhythms in clock proteins in the mouse pars tuberalis depend on MT1 melatonin receptor signalling

  2005cited by this paper
• Molecular tools to study melatonin pathways and actions.

  2005cited by this paper
• Involvement of the cGMP signalling pathway in the regulation of viability in insulin‐secreting BRIN‐BD11 cells

  2004cited by this paper
• Indication of circadian oscillations in the rat pancreas

  2004cited by this paper
• Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers

  2004cited by this paper
• Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters

  2003cited by this paper
• Targeted Disruption of the Mouse Mel1b Melatonin Receptor

  2003cited by this paper
• cGMP-dependent protein kinase II modulates mPer1 and mPer2 gene induction and influences phase shifts of the circadian clock.

  2003cited by this paper
• Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats

  2003cited by this paper
• Identification and functional characterization of melatonin Mel 1a receptors in pancreatic β cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling

  2002cited by this paper
• Output pathways of the mammalian suprachiasmatic nucleus: coding circadian time by transmitter selection and specific targeting

  2002cited by this paper
• Receptor (MT1) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS‐1

  2002cited by this paper
• Daily rhythm of glucose‐induced insulin secretion by isolated islets from intact and pinealectomized rat

  2002cited by this paper
• Mammalian melatonin receptors: molecular biology and signal transduction

  2002cited by this paper
• Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure.

  2002cited by this paper
• Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity

  2002cited by this paper
• Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin

  2002cited by this paper
• Role for the Pineal and Melatonin in Glucose Homeostasis: Pinealectomy Increases Night‐Time Glucose Concentrations

  2001cited by this paper
• Melatonin Receptor Signaling: Finding the Path Through the Dark

  2001cited by this paper
• Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic, and molecular investigations

  2000cited by this paper
• cAMP-GEFII is a direct target of cAMP in regulated exocytosis

  2000cited by this paper
• Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins.

  1999cited by this paper
• Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes.

  1999cited by this paper
• Daily Melatonin Administration at Middle Age Suppresses Male Rate Visceral Fat, Plasma Leptin, and Plasma Insulin to Youthful Levels.

  1999cited by this paper
• DIURNAL VARIATIONS IN INSULIN SECRETION AND K+ PERMEABILITY IN ISOLATED RAT ISLETS

  1999cited by this paper
• Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels.

  1999cited by this paper
• Evidence for a circadian rhythm of insulin release from perifused rat pancreatic islets

  1998cited by this paper
• The Mel1a melatonin receptor is coupled to parallel signal transduction pathways.

  1997cited by this paper
• The Mel1a Melatonin Receptor Is Coupled to Parallel Signal Transduction Pathways 1.

  1997cited by this paper
• Role of the pineal gland and melatonin in the development of autoimmune diabetes in non‐obese diabetic mice

  1996cited by this paper
• Evidence for a circadian rhythm of insulin secretion.

  1996cited by this paper
• Nature's knockout: the Mel1b receptor is not necessary for reproductive and circadian responses to melatonin in Siberian hamsters.

  1996cited by this paper
• Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor.

  1995cited by this paper
• Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses.

  1994cited by this paper
• Guanosine 3':5'-monophosphate-dependent protein kinases in mammalian tissues.

  1974cited by this paper

• Chrononutrition: Potential, Challenges, and Application in Managing Obesity

  2025cites this paper
• Interrelationship between type 2 diabetes mellitus and obstructive sleep apnea: Experts’ opinion with focus on development of a screening tool

  2025cites this paper
• Melatonin Supplementation Improves Cognitive Function in Type-2 Diabetes Mellitus: A Quasi-Experimental Study

  2025cites this paper
• Cell‐Specific Functions of the BAI/ADGRB Subfamily of Adhesion G‐Protein Coupled Receptors

  2025cites this paper
• Effectiveness of evocalcet for hypercalcemia in patients with primary hyperparathyroidism

  2025cites this paper
• Unraveling the complex relationship between night shift work and diabetes: exploring mechanisms and potential interventions

  2025cites this paper
• Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies.

  2024cites this paper
• Serum melatonin levels in type 2 diabetic patients with depressive symptoms compared to non-depressed individuals

  2024cites this paper
• Decoding the Significance of Alpha Cell Function in the Pathophysiology of Type 1 Diabetes

  2024cites this paper
• Exploring effects of melatonin supplementation on insulin resistance: An updated systematic review of animal and human studies.

  2024cites this paper
• Melatonin effects on animal behavior: circadian rhythm, stress response, and modulation of behavioral patterns

  2024cites this paper
• Diet, lifestyle and gut microbiota composition among Malaysian women with gestational diabetes mellitus: a prospective cohort study

  2024cites this paper
• Melatonin, Circadian Rhythms, and Type 2 Diabetes Mellitus: A Comprehensive Review of Epidemiology, Molecular Mechanisms, and Therapeutic Implications

  2024cites this paper
• Поиск новых иммуногистохимических и циркулирующих маркеров инсулиномы

  2024cites this paper
• Association between napping and type 2 diabetes mellitus

  2024cites this paper
• Pelabresib (CPI-0610): An Exciting Novel Drug for the Treatment of Myelofibrosis

  2023cites this paper
• Melatonin receptor 1A (MTNR1A) gene linkage and association to type 2 diabetes in Italian families.

  2023cites this paper
• Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.

  2023cites this paper
• Comparative metabolomics analysis investigating the impact of melatonin-enriched diet on energy metabolism in the crayfish, Cherax destructor

  2023cites this paper
• Shift Work and Metabolic Syndrome Updates: A Systematic Review

  2023cites this paper
• Melatonin increases susceptibility to atrial fibrillation in obesity via Akt signaling impairment in response to lipid overload

  2023cites this paper
• A novel combination of sitagliptin and melatonin ameliorates T2D manifestations: studies on experimental diabetic models

  2023cites this paper
• Circadian mechanism disruption is associated with dysregulation of inflammatory and immune responses: a systematic review

  2022cites this paper
• High circadian stimulus lighting therapy for depression: Meta-analysis of clinical trials

  2022cites this paper
• Melatonin Administration Prevents Placental and Fetal Changes Induced by Gestational Diabetes

  2022cites this paper
• Anti-Inflammatory Effects of Melatonin in Rats with Induced Type 2 Diabetes Mellitus

  2022cites this paper
• Circadian Disruption of Melatonin among Night Shift Workers and Its Effect on Glycemic Variability

  2022cites this paper
• Treatment with crocin suppresses diabetic nephropathy progression via modulating TGF-β1 and oxidative stress in an experimental model of pinealectomized diabetic rats.

  2021cites this paper
• Melatonin, A Promising Therapeutic for Diabetes Mellitus and Its Complications: A Narrative Review

  2021cites this paper
• New Targets for Drug Therapy in Type 2 Diabetes Mellitus

  2021cites this paper
• Potential therapeutic value of melatonin in diabetic nephropathy: improvement beyond anti-oxidative stress

  2021cites this paper
• Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study

  2021cites this paper
• Microglial MT1 activation inhibits LPS‐induced neuroinflammation via regulation of metabolic reprogramming

  2021cites this paper
• The Melatonin Receptor MT2 Is Partly Involved in the Anti-Inflammatory Effects of Melatonin in Rats With Type 2 Diabetes Mellitus

  2021cites this paper
• Sleep Apnea, Obesity, and Disturbed Glucose Homeostasis: Epidemiologic Evidence, Biologic Insights, and Therapeutic Strategies

  2020cites this paper
• Combined administration of exogenous melatonin and insulin ameliorates streptozotocin induced toxic alteration on hematological parameters in diabetic male Wistar rats

  2020cites this paper
• Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection

  2020cites this paper
• Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19

  2020cites this paper
• Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes

  2020cites this paper
• Biorhythmic and receptor mediated interplay between melatonin and insulin: its consequences on diabetic erythrocytes

  2020influential citation
• Promising immunohistochemical and circulating markers of insulinoma

  2020cites this paper
• Melatonin restores Muc2 depletion induced by V. vulnificus VvpM via melatonin receptor 2 coupling with Gαq

  2020cites this paper
• Relationship between Intrinsically Photosensitive Ganglion Cell Function and Circadian Regulation in Diabetic Retinopathy

  2020cites this paper
• Melatonin in Medicinal and Food Plants: Occurrence, Bioavailability, and Health Potential for Humans

  2019cites this paper
• Social jetlag, circadian disruption, and cardiometabolic disease risk

  2019cites this paper
• Metabolic Consequences of Obstructive Sleep Apnea Especially Pertaining to Diabetes Mellitus and Insulin Sensitivity

  2019cites this paper
• Assessment of melatonin level and genetic aspect of type 2 diabetes mellitus patients in Thi-Qar province, Iraq

  2019cites this paper
• Association of common variant in the MTNR1B gene and risk of type 2 diabetes: Asian meta-analysis

  2019cites this paper
• Effect of Bedtime Melatonin Administration in Patients with Type 2 Diabetes: A Triple-Blind, Placebo-Controlled, Randomized Trial

  2019cites this paper
• Взаимное влияние обструктивного апноэ сна и метаболического синдрома

  2019cites this paper
• Association Between a Melatonin Receptor 1B Genetic Polymorphism and Its Protein Expression in Gestational Diabetes Mellitus

  2019cites this paper
• Correction to: Chronomedicine and type 2 diabetes: shining some light on melatonin

  2018cites this paper
• Studies of cAMP and Ca2+ signaling in pancreatic islet cells

  2018cites this paper
• Targeting oxidative stress through antioxidants in diabetes mellitus

  2018cites this paper
• Melatonin Receptor Agonist Piromelatine Ameliorates Impaired Glucose Metabolism in Chronically Stressed Rats Fed a High-Fat Diet

  2018cites this paper
• Melatonin inhibits apoptotic cell death induced by Vibrio vulnificus VvhA via melatonin receptor 2 coupling with NCF-1

  2018cites this paper
• The role of melatonin in the development of gestational diabetes

  2018cites this paper
• Melatonin improves hyperglycemia induced damages in rat brain

  2018cites this paper
• Effects of Streptozotocin-Induced Diabetes on the Pineal Gland in the Domestic Pig

  2018influential citation
• Interplay of central and peripheral circadian clocks in energy metabolism regulation

  2018cites this paper
• Melatonin in type 2 diabetes mellitus and obesity

  2018cites this paper
• Влияние экзогенного мелатонина на оксидативный статус и состояние перекисного окисления белков у крыс с моделью алиментарного ожирения

  2018cites this paper
• The role of melatonin in development of gestational diabetes mellitus

  2018cites this paper
• Значение мелатонина для деятельности почек

  2018cites this paper
• Melatonin attenuates smoking‐induced hyperglycemia via preserving insulin secretion and hepatic glycogen synthesis in rats

  2018cites this paper
• Melatonin as an effective pharmacocorrector of alimentary obesity resulting from a long-term excessive intake of palm oil

  2018cites this paper
• Metabolic disturbances: role of the circadian timing system and sleep

  2017cites this paper
• Analysis of MTNR1B gene polymorphisms in relationship with IRS2 gene variants, epicardial fat thickness, glucose homeostasis and cognitive performance in the elderly

  2017cites this paper
• Neu‐P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic‐pituitary‐adrenal axis in rats

  2017cites this paper
• Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease

  2017cites this paper
• Artificial light-at-night – a novel lifestyle risk factor for metabolic disorder and cancer morbidity

  2017cites this paper
• Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes

  2017cites this paper
• Running head : Piromelatine ameliorates glucose impairment in IR rats

  2017cites this paper
• Melatonin and the pathologies of weakened or dysregulated circadian oscillators

  2017cites this paper
• Chronomedicine and type 2 diabetes: shining some light on melatonin

  2017cites this paper
• Impact of Circadian and Sleep Disruption on Metabolic Health and Behavior

  2017cites this paper
• Lower nocturnal urinary 6-sulfatoxymelatonin is associated with more severe insulin resistance in patients with prediabetes

  2017cites this paper
• The Circadian Timing System and Endocrine Physiology

  2016cites this paper
• Genetics of Gestational Diabetes Mellitus and Maternal Metabolism

  2016cites this paper
• Circadian Clocks: Role in Health and Disease

  2016cites this paper
• Melatonin suppresses autophagy in type 2 diabetic osteoporosis

  2016cites this paper
• Beneficial effects of melatonin and alpha lipoic acid on lopinavir/ ritonavir-induced alterations in serum lipid and glucose levels of male albino rats

  2016cites this paper
• A nested case–control study of the association between melatonin secretion and incident myocardial infarction

  2016cites this paper
• Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis.

  2016cites this paper
• The Role of Melatonin on GLUT-1 Expression in Rat Testicular Tissue Metabolism in Metabolic Syndrome

  2016cites this paper
• Manipulating the Circadian and Sleep Cycles to Protect Against Metabolic Disease

  2015cites this paper
• Diabetes Pathology and Risk of Primary Open-Angle Glaucoma: Evaluating Causal Mechanisms by Using Genetic Information.

  2015cites this paper
• Consequences of Circadian Disruption on Cardiometabolic Health.

  2015cites this paper
• Melatonin prevents hyperglycemia in a model of sleep apnea.

  2015cites this paper
• Manipulating the circadian and sleep cycles to protect against metabolic disease

  2015cites this paper
• Melatonin and brain inflammaging.

  2015cites this paper
• Effect of glucagon on insulin secretion through cAMP signaling pathway in MIN6 cells.

  2015cites this paper
• Exploring the Physiological Link between Psoriasis and Mood Disorders

  2015cites this paper
• Experimental and clinical aspects of melatonin and clock genes in diabetes

  2015influential citation
• How Shift Work and a Destabilized Circadian System may Increase Risk for Development of Cancer and Type 2 Diabetes

  2015cites this paper
• Efeitos do trabalho noturno nos ritmos circadianos de marcadores do processo inflamatório

  2015cites this paper
• Calcium‐signaling components in rat insulinoma β‐cells (INS‐1) and pancreatic islets are differentially influenced by melatonin

  2014cites this paper
• Melatonin administration in diabetes: regulation of plasma Cr, V, and Mg in young male Zucker diabetic fatty rats.

  2014cites this paper
• The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension

  2014cites this paper
• Melatonin receptors in diabetes: a potential new therapeutical target?

  2014cites this paper